Hookipa Pharma Inc.

12/07/2020 | Press release | Distributed by Public on 12/07/2020 05:02

HOOKIPA Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability